These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15994622)

  • 1. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
    Westhoff C; Osborne LM; Schafer JE; Morroni C
    Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
    Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
    Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended regimens of the vaginal contraceptive ring: cycle control.
    Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
    Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
    Schwarz BE; Pierce C; Walden CE; Knopp RH
    Int J Fertil; 1992; 37(3):176-82. PubMed ID: 1355765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
    Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
    Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended regimens of the contraceptive vaginal ring: a randomized trial.
    Miller L; Verhoeven CH; Hout Ji
    Obstet Gynecol; 2005 Sep; 106(3):473-82. PubMed ID: 16135576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
    Bruni V; Pontello V; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
    Hamerlynck JV; Vollebregt JA; Doornebos CM; Muntendam P
    Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
    Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
    Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
    Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
    Milsom I; Lete I; Bjertnaes A; Rokstad K; Lindh I; Gruber CJ; Birkhäuser MH; Aubeny E; Knudsen T; Bastianelli C
    Hum Reprod; 2006 Sep; 21(9):2304-11. PubMed ID: 16763008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
    Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
    Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaginal contraceptive pill.
    Coutinho E
    IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
    Nakajima ST; Archer DF; Ellman H
    Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.
    Schlaff WD; Lynch AM; Hughes HD; Cedars MI; Smith DL
    Am J Obstet Gynecol; 2004 Apr; 190(4):943-51. PubMed ID: 15118618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.